The General Questions of Anaesthesiology
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pain Management
BLBK137-Paul February 20, 2009 13:17 CHAPTER 8 8 Pain management Mark Nichols MD, Glenna Halvorson-Boyd PhD, RN, Robert Goldstein MD, Clifford Gevirtz MD, MPH and David Healow MD LEARNING POINTS r Proper selection of medications and nonpharmacological interventions reduces pain and anxiety and enhances patient satisfaction. r Several effective techniques exist for administration of local cervical anesthesia. Limited data support use of deep injections and adjunctive premedication with nonsteroidal antiinflammatory drugs. r The most common conscious sedation regimen used by North American abortion providers is a combination of fentanyl and midazolam. r Deep sedation and general anesthesia carry important benefits for certain patients, but they require specialized personnel and equipment. Introduction Pain associated with abortion Managing pain associated with abortion procedures is an es- Pain management remains an important challenge in abor- sential goal in the care of patients requesting pregnancy ter- tion practice, although studies suggest that progress in pain mination. Effective methods range from local cervical anes- control has been achieved over time in the USA. In a sur- thesia, with or without supplemental oral or intravenous vey in the late 1970s, 2,299 women having abortions with (IV) medications, to general anesthesia (GA). A number cervical anesthesia were asked to rate their pain as “mild, of factors influence the options available to patients, in- moderate, or severe.” Forty-six per cent called the pain mod- cluding local regulations, safety considerations, facility in- erate, and 32% called it severe. [2] A survey conducted two frastructure and resources, cost, and insurance coverage. decades later of more than 2,000 patients at 12 abortion fa- In the USA, where most abortions occur in freestanding cilities in the USA found that 30% of patients felt no pain, clinics, cervical anesthesia with or without IV conscious 25% mild pain, 29% moderate pain, and 14% severe pain. -
Perioperative Opioid Administration
REVIEW ARTICLE Deborah J. Culley, M.D., Editor ABSTRACT Opioids form an important component of general anesthesia and periopera- tive analgesia. Discharge opioid prescriptions are identified as a contributor for persistent opioid use and diversion. In parallel, there is increased enthu- Perioperative Opioid siasm to advocate opioid-free strategies, which include a combination of known analgesics and adjuvants, many of which are in the form of continuous Administration infusions. This article critically reviews perioperative opioid use, especially in view of opioid-sparing versus opioid-free strategies. The data indicate that A Critical Review of Opioid-free versus opioid-free strategies, however noble in their cause, do not fully acknowledge the limitations and gaps within the existing evidence and clinical practice con- Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/134/4/645/512461/20210400.0-00024.pdf by guest on 24 September 2021 Opioid-sparing Approaches siderations. Moreover, they do not allow analgesic titration based on patient needs; are unclear about optimal components and their role in different sur- Harsha Shanthanna, M.D., Ph.D., F.R.C.P.C., gical settings and perioperative phases; and do not serve to decrease the Karim S. Ladha, M.D., M.Sc., F.R.C.P.C., risk of persistent opioid use, thereby distracting us from optimizing pain and Henrik Kehlet, M.D., Ph.D., minimizing realistic long-term harms. Girish P. Joshi, M.B.B.S., M.D., F.F.A.R.C.S.I. (ANESTHESIOLOGY 2021; 134:645–59) ANESTHESIOLOGY 2021; 134:645–59 At the same time, this seems to have precipitated a pioids are an integral part of perioperative care rethinking around the use of opioids during the periop- Obecause of their high analgesic efficacy.1–3 They have erative period, and anesthesiologists are identifying the well-known short-term adverse effects and the potential role they can play in decreasing the burden of the opioid for long-term adverse effects for patients and society.3–5 crisis. -
Effect of Local Infiltration Analgesia, Peripheral Nerve Blocks, General
Berninger et al. BMC Musculoskeletal Disorders (2018) 19:232 https://doi.org/10.1186/s12891-018-2154-z RESEARCHARTICLE Open Access Effect of local infiltration analgesia, peripheral nerve blocks, general and spinal anesthesia on early functional recovery and pain control in total knee arthroplasty M. T. Berninger1,2* , J. Friederichs2, W. Leidinger3, P. Augat4,5, V. Bühren2, C. Fulghum1 and W. Reng1 Abstract Background: Postoperative pain control and enhanced mobilization, muscle strength and range of motion following total knee arthroplasty (TKA) are pivotal requisites to optimize rehabilitation and early recovery. The aim of the study was to analyze the effect of local infiltration analgesia (LIA), peripheral nerve blocks, general and spinal anesthesia on early functional recovery and pain control in primary total knee arthroplasty. Methods: Between January 2016 until August 2016, 280 patients underwent primary TKA and were subdivided into four groups according to their concomitant pain and anesthetic procedure with catheter-based techniques of femoral and sciatic nerve block (group GA&FNB, n = 81) or epidural catheter (group SP&EPI, n = 51) in combination with general anesthesia or spinal anesthesia, respectively, and LIA combined with general anesthesia (group GA&LIA, n = 86) or spinal anesthesia (group SP&LIA, n = 61). Outcome parameters focused on the evaluation of pain (NRS scores), mobilization, muscle strength and range of motion up to 7 days postoperatively. The cumulative consumption of (rescue) pain medication was analyzed. Results: Pain relief was similar in all groups, while the use of opioid medication was significantly lower (up to 58%) in combination with spinal anesthesia, especially in SP&EPI. -
Epidural and Wound Infiltration Analgesia in Patients: Received: 11-11-2017 Accepted: 15-12-2017 a Comparative Study
International Journal of Medical Anesthesiology International Journal of Medical Anesthesiology 2018; 1(1): 10-12 E-ISSN: 2664-3774 P-ISSN: 2664-3766 IJMA 2018; 1(1): 10-12 Epidural and wound infiltration analgesia in patients: Received: 11-11-2017 Accepted: 15-12-2017 A comparative study Dr. Vijay Acharya Department of Anesthesia, Dr. Vijay Acharya T. D. Medical College, Alappuzha, Kerala, India Abstract Background: The present study was conducted to compare epidural and wound infiltration analgesia in study group. Materials & Methods: The present study was conducted in the department of Anesthesia. It comprised of 64 patients aged 30–70 years belonging to the American society of Anesthesiologists physical status 1 and 2. Patients were divided into 2 groups of 32 each. Group I were those in which epidural infiltration was given and group II were those in which wound infiltration was done. Patients were evaluated for visual analogue score at rest (VASR) and at deep breathing (VASDB) post‑ operatively. Results: There was non- significant difference (P> 0.05) in VAS score recorded in both groups at 10 minutes, 20 minutes, 60 minutes, 90 minutes, 120 minutes and 180 minutes at rest whereas it was significant at deep breadth (P< 0.05). In group I 1 and in group II 2 had side effects. Conclusion: Continuous epidural infusion is better as compared to Continuous wound infiltration. Side effects were also less in continuous epidural infusion group. Keywords: Continuous epidural infusion, VAS, wound infiltration Introduction Microdiscectomy is performed in symptomatic patients whose disabling pain and functional impairment have failed to respond to adequate trials of conservative treatment.1 Postoperative pain derived from this minimally invasive procedure can further cause discomfort and if persistent, may lead to chronic pain. -
Neuroanesthesia Checklists
Neuroanesthesia Checklists Contents: 1. Surgical resection of Arteriovenous Malformation (AVM) 2. Deep Brain Stimulation (DBS) 3. Flexible Endoscopic Intubation 4. Checklist: Prone Positioning Lumbar Spine Surgery 5. Moyamoya / Extra- Intracranial Bypass 6. Lidocaine Infusions for Trigeminal Nerve Neurolysis in Neuroradiology Suite 7. Checklist for Stroke – Endovascular Therapy 8. Craniotomy for Resection of Supratentorial Tumor 9. SNACC Neuroanesthetic Emergencies Critical Event Treatment Guides Surgical resection of Arteriovenous Malformation (AVM) Surgical characteristics Duration of surgery Variable. Between 6 to 12 hours. Expected blood loss Variable. Potential high blood loss during the procedure. Blood group confirmation is mandatory. Positioning Depending on the location of AVM Antibiotic therapy As per surgical protocol. Anesthesia Pre-Anesthesia Optimize pre-existing medical conditions. Review the size, location and characteristics of AVM. Was endovascular embolization performed prior to surgery? Mode of Anesthesia Usually general anesthesia. Consider TIVA (Propofol). Airway Standard management / avoid sympathetic response to laryngoscopy. Ventilation Normoventilation. Mild hyperventilation (paCO2 28-33 mmHg) may be indicated in selected cases. Target MAP Initially maintain normotension. Discuss BP management with surgeon, often deliberate hypotension needed. Blood Gases Perform frequently – and as needed to control pCO2. Temperature Maintain normothermia. Use Bear Hugger blankets. Avoid hyperthermia. Transfer Consider ICU for postoperative BP control Special Potential major blood loss during procedure. considerations Be prepared to provide deliberate hypotension. Consider e.g. Esmolol (1 mg/kg, 0.5 mg/kg/min infusion), Labetalol, Nitroglycerin infusion. Often intraoperative angiogram. Indocyanine green dye sometimes used. Patient monitoring and vascular access Patient monitoring Standard CAS monitoring. Peripheral IV access Minimal 2 peripheral IV lines, one suitable for rapid infusion. -
Intraoperative Local Infiltration Analgesia for Early Analgesia After Total Hip Arthroplasty a Randomized, Double-Blind, Placebo-Controlled Trial
ORIGINAL ARTICLE Intraoperative Local Infiltration Analgesia for Early Analgesia After Total Hip Arthroplasty A Randomized, Double-Blind, Placebo-Controlled Trial Troels H. Lunn, MD,*Þ Henrik Husted, MD,Þþ Søren Solgaard, MD, DMSc,Þ§ Billy B. Kristensen, MD,*Þ Kristian S. Otte, MD,Þþ Anne G. Kjersgaard, MD,Þ§ Lissi Gaarn-Larsen, RNA,Þ and Henrik Kehlet, MD, PhDÞ|| ncreasing focus has been made on optimizing pain manage- Background and Objectives: High-volume local infiltration anal- Iment after total hip arthroplasty (THA) as a prerequisite for gesia (LIA) is widely applied as part of a multimodal pain management early recovery and rehabilitation. Epidural analgesia and pe- strategy in total hip arthroplasty (THA). However, methodological pro- ripheral nerve blockade provide good pain control,1Y3 but both blems hinder the exact interpretation of previous trials, and the evidence techniques may have inherent risk of partial motor blockade, for LIA in THA remains to be clarified. Therefore, we evaluated whether potentially delaying early postoperative mobilization. intraoperative high-volume LIA, in addition to a multimodal oral anal- Local infiltration analgesia (LIA) was introduced by Kerr gesic regimen, would further reduce acute postoperative pain after THA. and Kohan.4 The technique covers a systematic intraoperative Methods: Patients scheduled for unilateral, primary THA under spinal infiltration of a high-volume analgesic mixture (ropivacaine, anesthesia were included in this randomized, double-blind, placebo- ketorolac, and epinephrine) into the surgical wound along with controlled trial receiving high-volume (150 mL) wound infiltration with K subsequent postoperative injections through an intra-articular ropivacaine 0.2% with epinephrine (10 g/mL) or saline 0.9%. -
Issues Related to the Management of Postoperative Pain
Ask the Experts: Issues Related to the Management of Postoperative Pain Presented as a Live Webinar Thursday, February 13, 2014 1:00 p.m. – 2:00 p.m. ET Planned and conducted by ASHP Advantage and supported by an educational grant from Pacira Pharmaceuticals, Inc. Ask the Experts: Issues Related to the Management of Postoperative Pain Webinar Information How do I register? Go to http://www.ashpadvantagemedia.com/postoppain/webinar.php and click on the Register button. After you submit your information, you will be e-mailed computer and audio information. What is a live webinar? A live webinar brings the presentation to you – at your work place, in your home, through a staff in- service program. You listen to the speaker presentation in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program. Please join the conference at least 5 minutes before the scheduled start time for important announcements. How do I process my Continuing Education (CE) credit? Continuing pharmacy education for this activity will be processed on ASHP’s new eLearning system and reported directly to CPE Monitor. After completion of the live webinar, you will process your CPE and print your statement of credit online at http://elearning.ashp.org/my-activities. To process your CPE, you will need the enrollment code that will be announced at the end of the webinar. View full CE processing instructions What if I would like to arrange for my colleagues to participate in this webinar as a group? One person serving as the group coordinator should register for the webinar. -
Orientation for New Clinicians
PROFESSIONAL AFFAIRS ORIENTATION FOR NEW CLINICIANS TABLE OF CONTENTS SCORE: CLINICAL ORIENTATION ........................................................................................... 4 I. SCHEDULE ........................................................................................................................ 5 A. QGenda ......................................................................................................................... 5 B. Weekly Schedule .......................................................................................................... 5 C. OR Daily Schedule ....................................................................................................... 5 D. Anesthesia Daily Call Team ......................................................................................... 6 II. ELECTRONIC MEDICAL RECORD ............................................................................... 6 A. BIDMC Portal: ............................................................................................................. 6 B. Anesthesia Intranet ....................................................................................................... 6 C. Perioperative Information Management System (PIMS) ............................................. 7 D. Talis: ............................................................................................................................. 7 E. Online Medical Record (OMR): .................................................................................. -
Comparison of Perioperative Analgesia Using the Infiltration Of
O.L. Carapeba et al. BMC Veterinary Research (2020) 16:88 https://doi.org/10.1186/s12917-020-02303-9 RESEARCH ARTICLE Open Access Comparison of perioperative analgesia using the infiltration of the surgical site with ropivacaine alone and in combination with meloxicam in cats undergoing ovariohysterectomy Gabriel de O.L. Carapeba1, Isabela P. G. A. Nicácio1, Ana Beatriz F. Stelle2, Tatiane S. Bruno2, Gabriel M. Nicácio2, José S. Costa Júnior2, Rogerio Giuffrida1, Francisco J. Teixeira Neto3 and Renata N. Cassu1,2* Abstract Background: Infiltration of the surgical site with local anesthetics combined with nonsteroidal anti-inflammatory drugs may play an important role in improving perioperative pain control. This prospective, randomized, blinded, controlled clinical trial aimed to evaluate intraoperative isoflurane requirements, postoperative analgesia, and adverse events of infiltration of the surgical site with ropivacaine alone and combined with meloxicam in cats undergoing ovariohysterectomy. Forty-five cats premedicated with acepromazine/meperidine and anesthetized with propofol/isoflurane were randomly distributed into three treatments (n = 15 per group): physiological saline (group S), ropivacaine alone (1 mg/kg, group R) or combined with meloxicam (0.2 mg/kg, group RM) infiltrated at the surgical site (incision line, ovarian pedicles and uterus). End-tidal isoflurane concentration (FE’ISO), recorded at specific time points during surgery, was adjusted to inhibit autonomic responses to surgical stimulation. Pain was assessed using an Interactive Visual Analog Scale (IVAS), UNESP-Botucatu Multidimensional Composite Pain Scale (MCPS), and mechanical nociceptive thresholds (MNT) up to 24 h post-extubation. Rescue analgesia was provided with intramuscular morphine (0.1 mg/kg) when MCPS was ≥6. -
Standards for Office Based Anesthesia Practice
Standards for Office Based Anesthesia Practice Certified Registered Nurse Anesthetists (CRNAs) have long been the predominant anesthesia professional and leaders in providing anesthesia services in physicians’ offices. As the professional organization representing nurse anesthetists, the American Association of Nurse Anesthetists (AANA) advocates high quality, appropriate standards of care for all patients in all settings, including the office based practice setting. As in other settings, CRNAs provide anesthesia working with physicians such as surgeons, anesthesiologists and, where authorized, podiatrists, dentists and other healthcare professionals. The AANA has been at the forefront in establishing clinical practice standards, including patient monitoring standards. The standards for care in the office based setting are congruent with the AANA Scope and Standards for Nurse Anesthesia Practice and are intended to: 1. Provide assistance to CRNAs and other practitioners by promoting a common base for the delivery of quality patient care in the office based setting. 2. Assist the public in understanding what to expect from the practitioner. 3. Support the basic rights of patients. Although the standards are intended to promote high quality patient care, they cannot assure specific outcomes. There may be exceptional patient-specific circumstances that require deviation from a standard. The CRNA shall document any deviations from these standards (e.g., surgical interventions or procedures that invalidate application of a monitoring standard) and state the reason for the deviation on the patient’s anesthesia record. Anesthesia in the Office Setting There are some unique and specific responsibilities that should be considered prior to administration of anesthesia in the office setting. When considering an office based practice, anesthesia professionals should determine if there are appropriate resources to manage the various levels of anesthesia for the planned surgical procedures and the condition of the patient. -
Local Infiltration Anesthesia: Does It Really Work?
Editorial Page 1 of 3 Local infiltration anesthesia: does it really work? Saeid Safari1, Poupak Rahimzadeh1, Mohammad Haghighi2 1Department of Anesthesiology and Pain Medicine, Rasoul Akram Medical Center, Iran University of Medical Sciences, Tehran, Iran; 2Anesthesiology Research Center, Guilan University of Medical Sciences, Rasht, Iran Correspondence to: Mohammad Haghighi. Associated Professor, Anesthesiology Research Center, Guilan University of Medical Sciences, Rasht, Iran. Email: [email protected]. Submitted Aug 24, 2015. Accepted for publication Aug 25, 2015. doi: 10.3978/j.issn.2305-5839.2015.09.24 View this article at: http://dx.doi.org/10.3978/j.issn.2305-5839.2015.09.24 Postoperative pain control after major surgeries such as total Kohan to improve mobilization after THA and reduce hip arthroplasty (THA) is so important because leads to pain and opioids consumption (7). The results of this study an increased mobilization, decreased opioids consumption revealed that adding ketorolac to the ropivacaine and and hospital stay, all of which are the major concerns after epinephrine via LIA technique decreased the postoperative THA surgery. Perioperative local infiltration anesthesia pain score and opioids consumption; the addition of (LIA) is one of the recent techniques for achieving these epinephrine helps to reduce the toxicity of the local purposes (1-3). LIA to the operation site is a simple way and anesthetic by keeping it localized to the area of injection. have demonstrated great impacts on abdominal, thoracic, Hofstad et al. in their study have used perioperative LIA and plastic surgical setting. Actually, it is a widely used with ropivacaine in 116 patients under THA, and found no analgesic technique in recent years. -
(12) United States Patent (10) Patent No.: US 8,092.426 B2 Molnar (45) Date of Patent: *Jan
USOO8092426B2 (12) United States Patent (10) Patent No.: US 8,092.426 B2 Molnar (45) Date of Patent: *Jan. 10, 2012 (54) REGIONAL ANESTHESIA SYSTEMAND 5,647,373 A 7, 1997 Paltieli CART 5,700,147 A 12, 1997 Mills et al. 5,810,765 A 9, 1998 Oda 5,830,151 A 11/1998 HaZdic et al. (76) Inventor: James M. Molnar, Wyoming, OH (US) 6,022,337 A 2/2000 Herbst et al. - 6,055.458. A 4/2000 Cochran et al. (*) Notice: Subject to any disclaimer, the term of this 6,113,574 A 9/2000 Spinello patent is extended or adjusted under 35 6,179,829 B1 1/2001 Bisch et al. U.S.C. 154(b) by 0 days. 6,200,289 B1 3/2001 Hochman et al. This patent is Subject to a terminal dis- (Continued)Continued claimer. OTHER PUBLICATIONS (21) Appl. No.: 12/896,405 PCT International Search Report and Written Opinion for PCT/ US2009/042292 dated Dec. 16, 2009 (10 pages). (22) Filed: Oct. 1, 2010 (Continued) (65) Prior Publication Data Primary Examiner — Jackie Ho US 2011 FOO219 12 A1 Jan. 27, 2011 Assistant Examiner — Leah Stohr O O (74) Attorney, Agent, or Firm — Hasse & Nesbitt LLC; Related U.S. Application Data Ronald J. Richter; Donald E. Hasse (63) Continuation-in-part of application No. 12/114,634. filed on May 2, 2008, now Pat. No. 7,806,862. (57) ABSTRACT A regional anesthesia system and a cart for aiding in the (51) Int. Cl. placement of a regional anesthesia block without the need of A6M5/00 (2006.01) ancillary assistance.